September 14, 2017 - Eman Namati

Click to Signup Location: MIT Lincoln Laboratory, 3 Forbes Road, Lexington, MA 02420
Dinner Reservation Deadline: September 11, 2017 @ 6pm

Commercialization of an academic medical device, the road less travelled

The promise of making a difference and advancing healthcare drives many individuals in academia and industry to innovate, develop and commercialize medical devices. However, the road can be daunting, particularly from within the ‘safe’ confines of an academic setting. Here, I will discuss the ‘NinePoint’ story and the journey from academia through commercialization of an advanced optical imaging technology (Optical Coherence Tomography) for early diagnosis of Esophageal Cancer. I will share some personal vignettes and provide key takeaways for those interested in taking a similar path.

Eman Namati

Eman Namati is Vice President of R&D at NinePoint Medical in Bedford, MA. As a founding member of the company in 2010, he brought extensive scientific and technical expertise in the fields of medical imaging. Prior to joining NinePoint, Eman was a post-doctoral research fellow at Massachusetts General Hospital and Harvard Medical School working with Profs. Gary Tearney and Brett Bouma on the development of Optical Coherence Tomography – the core technology that was licensed to NinePoint. He helped build and lead the product development team, translating this academic technology into a commercial medical device in less than 3 years.

Reservations:

Dinner & Meeting reservations must be made by 6 PM, Monday September 11, 2017.  We can no longer accept dinner reservations after this cutoff.
Meeting-Only registrations are appreciated by Wednesday September 13, 2017.  Walk-ins are acceptable for the meeting-only.

Please make online reservations via the "Click to signup" button above.

Reservations may also be left on the answering machine at (617) 454-4693. We no longer have an email address for reservations due to SPAM.

When making reservation requests, please provide the following information:

  • DINNER AND MEETING or meeting only
  • Name(s) and membership status
  • Daytime phone number where you can be reached (in case of change or cancellation)

Location:

MIT Lincoln Laboratory
3 Forbes Road
Lexington, MA 02420

(Map to MIT Lincoln Laboratory)

Networking—5:45 PM, Dinner—6:45, Meeting—7:30 PM.

Menu:

Vegetarian option available on request

Dinner Prices:

   Register on/before
 DINNER Reservation Date 
 Late Reservations
Based on Availability
 NES/OSA Members and their guests   $30.00 each   $35.00 
 Non-members   $35.00 (See NOTE Below)   $40.00 
 Students   $5.00   $5.00 
 Post-Docs   $15.00   $15.00 

 

 

 

 

 

 

 

 

NOTE: The NES/OSA has not changed dinner prices in several years but has been facing higher costs. We have increased the cost of dinner by $5 this year. We will try to accommodate late reservations but cannot not guarantee that a meal will be available.

General Information on NES/OSA Meetings

Cancellations and No-shows:

If the meeting must be cancelled for any reason, we will try to call you at the phone number you leave with your reservation. Official notice of cancellation will be on our answering machine.

We have to pay for the dinners reserved as of the Tuesday before the meeting, so no-shows eat into our cash reserve. If you will not be able to attend, please let us know as early as possible. Otherwise, no-shows will be billed.

Membership Rates:

Regular members $15.00
Student members free

 

 

 

NOTE: The extra $5.00 of the non-member dinner fee can be used toward membership dues if the nonmember joins and pays dues for the current year at the meeting.

Click to Signup Location: MIT Lincoln Laboratory, 3 Forbes Road, Lexington, MA 02420
Dinner Reservation Deadline: September 11, 2017 @ 6pm

Commercialization of an academic medical device, the road less travelled

The promise of making a difference and advancing healthcare drives many individuals in academia and industry to innovate, develop and commercialize medical devices. However, the road can be daunting, particularly from within the ‘safe’ confines of an academic setting. Here, I will discuss the ‘NinePoint’ story and the journey from academia through commercialization of an advanced optical imaging technology (Optical Coherence Tomography) for early diagnosis of Esophageal Cancer. I will share some personal vignettes and provide key takeaways for those interested in taking a similar path.

Register to read more ...